baber/WOPTO huggingface dataset:
Patent NZ-540250-A (NZ)
Title: Reminder alarm for inhaler with variable and selectable ring tone alarms
Inventor: SUTHERLAND GARTH CAMPBELL
Filed: 2005-05-20
Abstract: A medicament inhaler is provided with a reminder system including a tone sounder 13 and a controller 11 with a timer 12 and a user interface. The tone sounder is controlled by the controller to output different ring tones at different times in accordance with programmed rules. The user interface allows the user to select the output ring tones from a plurality of ring tones. Of course, the controller is responsive to the actual use of the inhaler as detected by actuator detector 14 to provide reminder ring tone alarms as appropriate.
Patent NZ-541167-A (NZ)
Title: A rapid-acting pharmaceutical composition comprising e.g. fentanyl and particles insoluble in water
Inventor: NYSTROEM CHRISTER
IPC: A61K9/20
Filed: 2004-01-15
Abstract: Disclosed is a pharmaceutical composition for the treatment of acute disorders by sublingual or intranasal administration, comprising an ordered mixture of microparticles of at least one pharmaceutically active agent adhered to the surfaces of carrier particles, said particles being larger than said microparticles and being insoluble or sparingly soluble in water, and a bioadhesion and/or mucoadhesion promoting agent adhered to the surface of the carrier particles. Also disclosed is the use, in the manufacture of a medicament for the treatment of an acute disorder, of at least one pharmaceutically active agent in the form of microparticles adhered to the surfaces of carrier particles, which are larger than said microparticles and are essentially water-insoluble or sparingly water-soluble, and a bioadhesion and/or mucoadhesion promoting agent adhered to the surface of the carrier particles, wherein the medicament is formulated for sublingual or intranasal administration.
Patent NZ-542647-A (NZ)
Title: Tangential cutting insert and milling cutter
Inventor: SATRAN AMIR
IPC: B23C5/12
Filed: 2004-03-16
Abstract: A tangential cutting insert having first and second opposing end surfaces and a peripheral side surface extending therebetween. First and second edges are formed at the intersection of the first and second end surfaces with the peripheral side surface. A groove in the peripheral side surface extends between and intersects the first and second end surfaces at first and second minor edges. In first and second opposing side views of the cutting insert, at least the first edge is generally concave.
Patent NZ-544063-A (NZ)
Title: Stainless steel heater and sensor light
Inventor: WALTON PAUL
Filed: 2005-12-09
Abstract: A system1 with particular application to bathroom heating and lighting is disclosed. The apparatus includes a heater 7, a motion detector 2, an illuminating device 5, and a light sensor 10. The motion detector is activated when the light sensor detects little or no light and the illuminating device is activated when the motion detector is activated and senses movement.
Patent NZ-550127-A (NZ)
Title: Medical pump with lockout system
Inventor: VALEGO MATTHEW EDWARD
Filed: 2006-09-26
Abstract: An infusion pump with a fluid pump, a pump controller and a user interface for the controller which has a display and a set of pushbuttons for providing inputs to the controller when the pushbuttons are depressed in an unlocked state of the pump, is arranged with at least one of the pushbuttons having a multifunction so that it is operable when depressed and released in the unlocked state of the pump to provide an input for use in affecting the operation of the controller, and operable when it is depressed and held in a depressed position for a predetermined time interval (a couple of seconds) in the unlocked state of the pump to initiate a lockout state of the pump in which the push buttons including the said one push button are disabled from providing inputs to the controller.
Patent NZ-551231-A (NZ)
Title: Method and system for providing access to a channel for voice transmissions
Inventor: WIATROWSKI DAVID G
IPC: H04W4/10
Filed: 2005-06-06
Abstract: A method for allowing a subscriber unit to access a channel for voice transmission in a TDMA system is described. The TDMA system includes a number of subscriber units and a number of base radios. The method for allowing a first subscriber unit to access a channel for voice transmissions includes the steps of: - determining that the first subscriber unit is provisioned for polite access to the channel where the first subscriber unit is characterized by a first colour code and a first talkgroup ID; - examining the voice transmissions on the channel for voice transmissions that are from a second subscriber unit with a second colour code and a second talkgroup ID; and -if the first colour code and the second colour code match and the first talkgroup ID and the second talkgroup ID match, then allowing the first subscriber unit to access the channel for voice transmissions even though the channel is being used for voice transmissions by the second subscriber unit.
Patent NZ-552205-A (NZ)
Title: Phosphatidylinositol mannosides and analogues thereof
Inventor: PAINTER GAVIN FRANK
IPC: A61P31/00
Filed: 2006-12-20
Abstract: Disclosed is a phosphatidylinositol mannoside (PIM) analogue of the formula (I): where X1 and X2 are H, or taken together form a 6-membered carbocyclic ring which is optionally substituted with one or more groups selected from OH, halogen, alkyloxy, acyloxy and NH2; Y1 and Y2 are independently H, OH, or a saccharide having 1 to 5 glycosyl or glycosyloxy units and the other substituents are defined herein. Also disclosed is a pharmaceutical composition containing a compound as defined above, and one or more pharmaceutically acceptable carriers, excipients, or diluents. The use of a compound as defined above in the manufacture of a medicament for treating or preventing infection, an atopic disorder, or cancer is further disclosed.
Patent NZ-552541-A (NZ)
Title: Press twist closing device for containers
Inventor: DOBBELSTEIN PETER
IPC: B65D41/34
Filed: 2005-07-29
Abstract: The disclosure relates to a closing device on, or for, a sheet metal closing lid to be opened by rotation. Said closing device comprises a covering surface (10), a skirting section (20) located on the edge of the covering surface (10), and a sealing layer (25) which extends between a peripheral section of the covering surface and the skirting section. A securing ring (40, 30) consisting of a non-metal has two peripheral sections: a securing section (40) comprising a moulded strip section (41) which protrudes radially inwards and upwards, and a connecting section (30) for applying the securing section (40) to an axially lower end of the skirting section (20). The lower end (21, 21a) of the skirting section, rolled over more than 180 DEG , is at least partially surrounded (32, 32a, 32b) by the connecting section (30), by an inner side of the skirting section.
Patent NZ-552716-A (NZ)
Title: Oral dosage form safeguarded against abuse containing (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K9/22
Filed: 2005-06-29
Abstract: Disclosed is an abuse-proofed, oral dosage form with a breaking strength of at least 500 N and with a controlled release of the active ingredient (1R,2R)-3-(3-dimethylamino-1-ethyl2-methyl-propyl)phenol for once daily administration, which comprises the active ingredient and/or at least one of the pharmaceutically acceptable salts or derivatives thereof (A), at least one synthetic and/or natural polymer (C), optionally at least one delayed-release matrix material and/or optionally at least one delayed-release coating, at least one further physiologically acceptable auxiliary substance (B), and optionally at least one wax (D). Also disclosed is a process for the production of said abuse-proofed, oral dosage form, wherein (1) a mixture containing components (A), (C), optionally (B) and optionally (D) and optionally delayed-release matrix compounds and the optionally abuse-preventing components (such as nasal irritants, viscosity-increasing agent, aversive agent (dye) and a bitter substance) as a separate mixture is formed into formed articles by application of force, (2) the formed articles obtained are optionally singulated and optionally in each case graded by size and (3) after or during heating at least until component (C) softens, the formed articles are exposed to action of force until the formed articles exhibit breaking hardness of at least 500 N, and (4) are optionally provided with a coating, optionally a delayed-release or tastemasking coating and the formed articles are optionally all mixed together again.
Patent NZ-553526-A (NZ)
Title: Process for simulating the corrosive effects of refinery feedstocks on refinery mettalurgy
Inventor: BUTLER GRAHAM
IPC: G01N27/04
Filed: 2005-09-14
Abstract: A process for evaluating the corrosive effect of a refinery feedstock on the metallurgy of one or more refinery processes, said process comprising: (i) providing a plurality of refinery feedstocks and/or a plurality of fractions of one or more refinery feedstocks, (ii) providing an array comprising a plurality of metal samples representative of metallurgy present in a refinery, (iii) contacting each of the plurality of metal samples with one or more of said refinery feedstocks or fractions under non-static conditions, and (iv) determining the corrosive effect of said feedstock and/or fraction on the metal sample.
Patent NZ-564694-A (NZ)
Title: Peptide vectors
Inventor: DONG ZHENG XIN
IPC: A61K47/48
Filed: 2004-04-21
Abstract: Disclosed is a protein-camptothecin conjugate according to the formula X-B1-B2-B3-B4-Z wherein: X is selected from camptothecin or a camptothecin derivative; Each of B1, B2, B3 and B4 is independently for each occurrence (Doc)m, (Aepa)n, -(C(O)-A1-A2-A3-A4-A5-C(O))s- or (amino acid)p; wherein the amino acid is selected from the group consisting of Gly, Val, Abu, Gaba, Doc, and Sar; each of A1 and A5 is, for each occurrence, CH2; each of A2, A3, and A4 is, independently for each occurrence, CH2 or (CH2)t or absent; integers m, n, p, s and t are as described in the specification; and Z is a peptide selected from the list of -Lys-DTyr-DTyr-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2 ; -DPhe-cyclo(Cys-Tyr-DTrp-Lys-Abu-Cys)-Thr-NH2 ; -DPhe-cyclo(Cys-3ITyr-DTrp-Lys-Val-Cys)-Thr-NH2; -Gln-Trp-Ala-Val-betaAla-His-Leu-Leu-NH2 ; -DPhe-Gln-Trp-Ala-Val-betaAla-His-Leu-Leu-NH2 ; -Gln-Trp-Ala-Val-betaAla-His-Leu-Nle-NH2 ; -DCys-3Pal-DTrp-Lys-DCys-Thr-Tyr-NH2; and -pGlu-His-Trp-Ser-Tyr-DLys[Nepsilon~]-Leu-Arg-Pro-Gly-NH2; or a pharmaceutically acceptable salt thereof. In particular the conjugated protein may be a somatostatin, LHRH or bombesin analogue. The compounds disclosed are useful as targeted cytotoxic agents. Also disclosed herein are intermediates for the production of compounds of formula (I).
Patent NZ-565868-A (NZ)
Title: Platform for a dish washing machine
Inventor: KUCUK CENGIZ
IPC: A47L15/42
Filed: 2006-08-10
Abstract: The tub unit 25 of a dishwashing machine has walls 11, 19, 17, 18 of non-rusting metal and a plastics base or mounting floor 16 to which the walls are attached and which together form the washing compartment which is closed by a door and a housing (not shown). The lower wall 3 of the washing compartment is formed by the plastic mounting floor 16, and the visible surface of the washing compartment lower wall in the interior of the washing compartment is provided with a pattern, colour or material layer so that the appearance of the lower wall surface is different from the appearance of the plastic of the remainder of the mounting floor. More particular, the idea is to make the lower floor look as though it is of stainless steel or other "high quality" material, even though it is "only plastic".
Patent NZ-566239-A (NZ)
Title: Method to increase resistance against stain penetration of aqueous coating compositions
Inventor: CHOWDHRY MUBARIK MAHMOOD
IPC: C09D7/12
Filed: 2006-09-11
Abstract: The disclosure relates to a method for improving stain resistance and penetration resistance of aqueous coating compositions, which method comprises providing a coating composition which contains at least one pigment, at least one film-forming polymer in the form of an aqueous polymer dispersion and at least one anionic surfactant, wherein the anionic surfactant comprises at least 85 % by weight, based on the total weight of anionic surfactant in the coating composition, of at least one anionic surfactant S, which is selected from semi-esters of sulfuric acid or phosphoric acid with an alcohol A, which alcohol A carries at least one alkyl radical having from 8 to 30 carbon atoms or an alkyl substituted phenyl radical wherein alkyl has from 4 to 30 carbon atoms and which alcohol A may carry an oIigo-C2-C3 alkylene- ether group provided that the number of repeating units in the oIigo-C2-C3- alkylene-ether group is at most 15, or a salt thereof.
Patent NZ-566458-A (NZ)
Title: Air dryer system with moist air inlet plenum and dry air outlet plenum
Inventor: MAHONEY THOMAS JOHN
Filed: 2008-03-05
Abstract: A plurality of air drying units are disclosed, which can be used in combination. The drying units 20 comprise a moist air inlet plenum 36 and a dry air outlet plenum 34. Each of the air drying units 22, 24, 26 includes a pair of substantially identical air drying canisters 64, 66 and a single lower base 28 30 32. Each of the single lower bases also includes a single flanged mounting bracket 38, 40, 42. The moist air inlet plenum is operatively associated with each of these bases by single moist air inlet means for each base. The inlet means is located at predetermined fixed intervals along the moist air inlet plenum. The dry air outlet plenum is operatively associated with each of the bases mentioned by single dry outlet means for each base. The outlet means is located at predetermined fixed intervals along the dry air plenum. Incoming moist air is fed from the bases to a dry air facility which is located downstream of the dry air plenum.
Patent NZ-568483-A (NZ)
Title: An electrostatic precipitator
Inventor: CLARK JAMES MCDONALD
IPC: B03C3/06
Filed: 2003-11-11
Abstract: An electrostatic precipitator is provided. The electrostatic precipitator comprises a conduit for the passage of particles in an air flow. The electrostatic precipitator also comprises means for generating an electrostatic field substantially orthogonal to the air flow, and an ion supply capable of charging the particles. The generating means comprise a point electrode and a two dimensional surface electrode. The two dimensional surface electrode comprises an ion source. The point electrode comprises a counter electrode, which is earthed. The conduit is a hollow parallelpiped and the two dimensional surface electrode is adapted as a plurality of single polarity electrodes on one or more inner surfaces of the conduit. (62) Divided Out of 540622
Patent NZ-574438-A (NZ)
Title: Process cheese and method of producing the same
Inventor: UEDA NAOYASU
IPC: A23C19/082
Filed: 2007-07-20
Abstract: Disclosed is a processed cheese, characterized by a blend of a starting cheese material that includes natural cheese and a pre-cooked cheese and has been heated at a high temperature of 110 degrees C or above together with all other ingredients, wherein the high temperature heated starting cheese material is contained in an amount of 1 to 50 percent by weight of the processed cheese. Also disclosed is a method of producing processed cheese, characterized the steps of: a. blending natural cheese with a pre-cooked cheese; b. heating the blend formed in step (a) above to a high temperature of 110 degrees C or above to form a high temperature heated starting cheese material; c. blending the high-temperature heated starting cheese material and all other ingredients, wherein the high-temperature heated starting cheese material is contained in an amount of 1 to 50 percent by weight of the processed cheese; d. heating and emulsifying the blend formed in step (c) above.
Patent NZ-576034-A (NZ)
Title: Process for the preparation of pleuromutilins
Inventor: MACHER INGOLF
IPC: A61K31/445
Filed: 2007-10-03
Abstract: Disclosed is a process for the preparation of piperidinylsulfanylacetylmutilins of formula I wherein the carbon atom of the piperidine ring attached to the sulphur atom is either in the (S)-configuration or in the (R)-configuration and the 2-amino-3-methyl-butyryl group attached to the piperidine ring is either in the (S)-configuration or in the (R)-configuration, comprising the steps of: a) deprotecting an N-protected piperidinylsulfanylacetylmutilin of formula II and isolating a compound of formula III wherein the carbon atom Of the piperidine ring attached to the sulphur atom is either in the (S)-configuration or in the (R)-configuration, in free form or in the form of an acid addition salt, in crystalline form, b) acylating said compound of formula III with either (R)- or (S)-valine protected as an enamine and activated as a carbonic acid mixed anhydride to form a compound of formula VI wherein R1 and R2 are C1-4 alkyl, and R, is hydrogen or C1-4 alkyl, deprotecting the compound of formula IV and isolating the compound of formula I. Also disclosed is a compound of formula (IV); the acid salt of formula (III) in crystalline form; 14-O-[(N-3-methyI-2-(R)-amino-butyryl-piperidine-3(S)- yl)sulfanyl)acetyl]mutilin hydrochloride; and a pharmaceutical composition containing crystalline 14-O-[(N-3-methyI-2-(R)-amino-butyryl-piperidine-3(S)- yl)sulfanyl)acetyl]mutilin hydrochloride
Patent NZ-576607-A (NZ)
Title: Pseudomonas rhodesiae ferm bp-10912 capable of controlling plant diseases
Inventor: MAEDA MITSUNORI
IPC: A01N63/27
Filed: 2007-11-06
Abstract: Disclosed is a Pseudomonas rhodesiae FERM BP-10912 having an antagonistic action against pathogenic bacteria of plant diseases. Also disclosed is a plant disease controlling agent containing a bacterial cell of Pseudomonas rhodesiae FERM BP-10912.
Patent NZ-578907-A (NZ)
Title: A dispenser with flaps restrained from separating from each other adjacent ends
Inventor: BUGELLI SILVIO
IPC: A47K10/42
Filed: 2009-08-06
Abstract: A dispenser (12) for dispensing thin flat articles in succession includes a dispensing face (16) with two flaps. The two flaps have meeting edges which are abutting or substantially adjacent to each other, to define a slit or slot therebetween for dispensing the flat articles therethrough. Each flap is hingeable along a hingeable portion opposite to its meeting edge. At or adjacent each end of the slit or slot, the flaps are restrained from separating from each other. The dispensing face may be embodied in a dispensing panel portion which is cut to define the flaps and the slit or slot therebetween, or has perforated or frangible portions which are selectively frangible to define the flaps and the slit or slot therebetween.
Patent NZ-580059-A (NZ)
Title: Door strike with selectable modes from power to open and power to close for striker
Inventor: MACKLE TREVOR
IPC: E05B15/02
Filed: 2007-08-16
Abstract: A door strike including: a latch retainer for retaining a door latch; a lock actuator which operates when power is applied; a mode selector rotatable between at least two positions; in a first position of the mode selector the strike adopts a power to open mode, in the second position of the mode selector the strike adopts a power to lock mode.
Patent NZ-581719-A (NZ)
Title: 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
Inventor: DOSSETTER ALEXANDER GRAHAM
IPC: A61P19/08
Filed: 2008-06-24
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation.  The compounds are reversible inhibitors of cysteine proteases, particular, cathepsin K, useful in the treatment of diseases such as osteoporosis, osteoarthritis, asthma, rheumatoid arthritis, metastatic bone disease, osteolytic bone cancer and bone related neuropathic pain.
Patent NZ-584049-A (NZ)
Title: (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
Inventor: DEFOSSA ELISABETH
IPC: A61K31/165
Filed: 2008-09-04
Abstract: Disclosed are (carboxylalkylenephenyl)phenyloxamides compounds and physiologically tolerated salts thereof of formula I, wherein the substituents are as defined in the specification. Also disclosed is their use in treating diabetes, CNS disorders, schizophrenia, Alzheimers and increasing insulin secretion.
Patent NZ-585280-A (NZ)
Title: Composition for regulating lipid metabolism
Inventor: BOURGEOIS-LUGAND MARIE FRANCOISE YVONNE
IPC: A23L33/155
Filed: 2008-10-16
Abstract: Disclosed is a composition designed to regulate lipid metabolism in humans and animals characterized in that said composition comprises, per l00g/100ml, the combination of: - 7 micro grams to 700 micro grams of at least two plant oils selected from among rapeseed oil, olive oil, grapeseed oil, and evening primrose oil, - 10 micro grams to 1000 micro grams of positively charged minerals selected from among sodium, magnesium, and calcium, - 10 micro grams to 1000 micro grams of metals chosen from among zinc and iron, - 7 micro grams to 700 micro grams of yeast or yeast extracts from the Saccharomyces serevisiae genus, characterized in that said yeasts or yeast extracts are enriched with Selenium, - 7 micro grams 700 micro grams of mushrooms or Shiitake (mycelium) mushroom extracts, - 6 micro grams to 600 micro grams of at least two vegetable extracts from plants chosen from among samphire, garlic, and grapevine, - 8 micro grams to 800 micro grams of at least one vitamin chosen from among vitamins A, B1, B9, C, E, F, and PP, - 7 micro grams 700 micro grams of an animal oil and Copra oil (Cocos nucifera) - 6 micro grams to 600 micro grams of at least one alga chosen from among Palmaria palmate (Dulse), Chondrus crispus (Carrageen), and Fucus vesiculosus (Bladder wrack), and a pharmaceutically and/or nutritionally acceptable excipient. Also disclosed is the use of the above mentioned composition in the preparation of a medicament or a nutritional product to regulate lipid metabolism in humans and animals.
Patent NZ-598534-A (NZ)
Title: Dosage regimen of an s1p receptor modulator
Inventor: DAVID OLIVIER
IPC: G16H40/63
Filed: 2010-09-20
Abstract: NZ 598534 Disclosed is the use of a therapeutically effective amount of a S1P receptor modulator or agonist, which is fingolimod in free form, in pharmaceutically acceptable salt form or fingolimod phosphate, in the manufacture of a medicament for treating an inflammatory or autoimmune disease or disorder in a patient in need thereof, wherein the adverse events possibly associated with administering said S1P receptor modulator or agonist are controlled, limited or abolished, wherein said medicament is adapted for administration to a patient that is monitored, before or during a specific period of time after the first administration of said medicament wherein the monitoring comprises step a) and step b); step a and step c); or steps a) and b) and c), where the steps a), b) and c) are defined as follows: a) monitoring and/or recording heart rate or blood pressure; b) testing history of viral infection or viral serology; c) monitoring and/or recording of infections or infestations; wherein the monitoring and/or recording may indicate that the administration of the medication to the patient should be interrupted and/or modified and/or a second drug should be administered which mitigates said adverse effects.